X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

Termination Payments - Changes to the taxation of UK termination payments

In this OnPoint, we report on two changes to the taxation of termination payments to departing emplo...

Read More >

U.S. P3 Market Year in Review

2019 was a banner year for public-private partnerships ("P3s") in the United States. More states tha...

Read More >

Ohio Supreme Court Upholds Constitutionality of State Statute Prohibiting Local Residency Requirements for Public Construction Projects

In a close 4 to 3 decision, the Ohio Supreme Court has affirmed the constitutionality of a state sta...

Read More >

Louisiana Court Upholds Ruling Allowing for the Reformation of a Noncompetition Agreement

The Louisiana Second Circuit Court of Appeal recently held that a noncompetition provision under La....

Read More >

NLRB: Property Owners May Limit Off-Duty Access By Contractors’ Employees

The National Labor Relations Board (NLRB) has ruled that a property owner lawfully may prohibit the ...

Read More >

SDNY Dismisses SOX and Dodd-Frank Whistleblower Claims Against Private Company

On June 3, 2019, the U.S. District Court for the Southern District of New York granted a defendant-e...

Read More >